OFFICIAL PUBLICATION OF

by its subsidiary APPco

Mixed news on Vyvanse shortage

Chris Brooker 08/03/2024

There has been good, and bad, news about the ongoing shortage of the ADHD treatment The Therapeutic Goods Administration (TGA) has an update informing of mixed news about ongoing shortages of Vyvanse (lisdexamfetamine dimesilate) capsules, with a resolution achieved for one strength of the drug, while the shortage of another has been extended. In a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Mixed news on Vyvanse shortage

Previous Man hurls abuse at CWH staff

Next ‘We hear and value all voices’

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Man hurls abuse at CWH staff

Next ‘We hear and value all voices’

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.